NFKB1 and cancer: It is becoming increasingly clear that the separate NF-κB subunits can have distinct roles in cancer cells contributing to tumorigenesis [152]; hence, specific inhibition of individual NF-κB subunits could be exploited for therapies against aberrant NF-κB activity with fewer side effects.